Haruka Tsuchiya1, Mineto Ota1,2, Keishi Fujio3. 1. Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033, Japan. 2. Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033, Japan. 3. Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033, Japan. fujiok-int@h.u-tokyo.ac.jp.
Abstract
BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune disease characterized by tumor-like hyperplasia and inflammation of the synovium, which causes synovial cell invasion into the bone and cartilage. In RA pathogenesis, various molecules in effector cells (i.e., immune cells and mesenchymal cells) are dysregulated by genetic and environmental factors. Synovial fibroblasts (SFs), the most abundant resident mesenchymal cells in the synovium, are the major local effectors of the destructive joint inflammation and exert their effects through the pathogenic production of molecules such as interleukin-6. MAIN BODY: To date, more than 100 RA susceptibility loci have been identified in genome-wide association studies (GWASs), and finding novel therapeutic targets utilizing genome analysis is considered a promising approach because some candidate causal genes identified by GWASs have previously been established as therapeutic targets. For further exploration of RA-responsible cells and cell type-specific therapeutic targets, integrated analysis (or functional genome analysis) of the genome and intermediate traits (e.g., transcriptome and epigenome) is crucial. CONCLUSION: This review builds on the existing knowledge regarding the epigenomic abnormalities in RASFs and discusses the recent advances in single-cell analysis, highlighting the prospects of SFs as targets for safer and more effective therapies against RA.
BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune disease characterized by tumor-like hyperplasia and inflammation of the synovium, which causes synovial cell invasion into the bone and cartilage. In RA pathogenesis, various molecules in effector cells (i.e., immune cells and mesenchymal cells) are dysregulated by genetic and environmental factors. Synovial fibroblasts (SFs), the most abundant resident mesenchymal cells in the synovium, are the major local effectors of the destructive joint inflammation and exert their effects through the pathogenic production of molecules such as interleukin-6. MAIN BODY: To date, more than 100 RA susceptibility loci have been identified in genome-wide association studies (GWASs), and finding novel therapeutic targets utilizing genome analysis is considered a promising approach because some candidate causal genes identified by GWASs have previously been established as therapeutic targets. For further exploration of RA-responsible cells and cell type-specific therapeutic targets, integrated analysis (or functional genome analysis) of the genome and intermediate traits (e.g., transcriptome and epigenome) is crucial. CONCLUSION: This review builds on the existing knowledge regarding the epigenomic abnormalities in RASFs and discusses the recent advances in single-cell analysis, highlighting the prospects of SFs as targets for safer and more effective therapies against RA.
Authors: Rizi Ai; John W Whitaker; David L Boyle; Paul Peter Tak; Danielle M Gerlag; Wei Wang; Gary S Firestein Journal: Arthritis Rheumatol Date: 2015-07 Impact factor: 10.995
Authors: John W Whitaker; Robert Shoemaker; David L Boyle; Josh Hillman; David Anderson; Wei Wang; Gary S Firestein Journal: Genome Med Date: 2013-04-30 Impact factor: 11.117
Authors: Josef S Smolen; Daniel Aletaha; Anne Barton; Gerd R Burmester; Paul Emery; Gary S Firestein; Arthur Kavanaugh; Iain B McInnes; Daniel H Solomon; Vibeke Strand; Kazuhiko Yamamoto Journal: Nat Rev Dis Primers Date: 2018-02-08 Impact factor: 52.329
Authors: Kyle Kai-How Farh; Alexander Marson; Jiang Zhu; Markus Kleinewietfeld; William J Housley; Samantha Beik; Noam Shoresh; Holly Whitton; Russell J H Ryan; Alexander A Shishkin; Meital Hatan; Marlene J Carrasco-Alfonso; Dita Mayer; C John Luckey; Nikolaos A Patsopoulos; Philip L De Jager; Vijay K Kuchroo; Charles B Epstein; Mark J Daly; David A Hafler; Bradley E Bernstein Journal: Nature Date: 2014-10-29 Impact factor: 49.962
Authors: Adam P Croft; Joana Campos; Kathrin Jansen; Jason D Turner; Jennifer Marshall; Moustafa Attar; Loriane Savary; Corinna Wehmeyer; Amy J Naylor; Samuel Kemble; Jenefa Begum; Kerstin Dürholz; Harris Perlman; Francesca Barone; Helen M McGettrick; Douglas T Fearon; Kevin Wei; Soumya Raychaudhuri; Ilya Korsunsky; Michael B Brenner; Mark Coles; Stephen N Sansom; Andrew Filer; Christopher D Buckley Journal: Nature Date: 2019-05-29 Impact factor: 49.962
Authors: Kevin Wei; Ilya Korsunsky; Jennifer L Marshall; Anqi Gao; Gerald F M Watts; Triin Major; Adam P Croft; Jordan Watts; Philip E Blazar; Jeffrey K Lange; Thomas S Thornhill; Andrew Filer; Karim Raza; Laura T Donlin; Christian W Siebel; Christopher D Buckley; Soumya Raychaudhuri; Michael B Brenner Journal: Nature Date: 2020-04-22 Impact factor: 49.962
Authors: Chiara Angiolilli; Pawel A Kabala; Aleksander M Grabiec; Iris M Van Baarsen; Bradley S Ferguson; Samuel García; Beatriz Malvar Fernandez; Timothy A McKinsey; Paul P Tak; Gianluca Fossati; Paolo Mascagni; Dominique L Baeten; Kris A Reedquist Journal: Ann Rheum Dis Date: 2016-07-25 Impact factor: 19.103